| |
 |
|
|
|
|
|
Poster: 106
Visits: 26
Title: An Integrated Analysis of Long Term Safety of an Extended Half-Life, Pegylated, Full-length Recombinant Factor VIII (BAX 855) in the Treatment of Hemophilia A in 234 Pediatric, Adolescent and Adult Patients
Authors: Jennifer Doralt , Anne Prener
Centre: Shire
|
|
You must be registered to reply or comment.
|
|
AN INTEGRATED ANALYSIS OF LONG TERM SAFETY OF AN EXTENDED HALF-LIFE, PEGYLATED, FULL-LENGTH RECOMBINANT FACTOR VIII (BAX 855) IN THE TREATMENT OF HEMOPHILIA A IN 234 PEDIATRIC, ADOLESCENT AND ADULT PATIENTS
|
|
| You must be registered to reply or comment. |
|
|
|
|
|
|
| Most viewed poster for this congress |
|
|
Poster: 13
Visits: 590
Title: Algorithmic evidence-based phenotype screening and collaborative approach to attacking symptoms of nonadherence in patients with bleeding disorders
Authors: Jay Bryant-Wimp , Jay Bryant-Wimp, RPh
Centre: Integrite Solutions
|
|
|
|
|
|
|
| Poster most viewed in this topic |
|
|
Poster: 97
Visits: 120
Title: Safety and efficacy of turoctocog alfa for prophylaxis and treatment of bleeding episodes in patients with severe hemophilia A: results from the guardian2 trial
Authors: Elena Santagostino ,
Centre: Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Maggiore Hospital Policlinico, Milan, Italy
|
|
|
|
